BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6431145)

  • 1. [Therapeutic results of malignant ovarian tumor].
    Fukazawa I; Masubuchi S; Okajima H; Fukuda K; Hayashi K; Yokosuka K; Miyata R; Masubuchi K
    Gan No Rinsho; 1984 Jun; 30(7):819-26. PubMed ID: 6431145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies of second-look operations (SLO) in ovarian cancer].
    Yuzawa H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1310-6. PubMed ID: 2658822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment and prognostic factors of epithelial ovarian cancer].
    Wei L; Qian H; Li W
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):476-9. PubMed ID: 9639741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian epithelial tumors of low malignant potential.
    Chien RT; Rettenmaier MA; Micha JP; DiSaia PJ
    Surg Gynecol Obstet; 1989 Aug; 169(2):143-6. PubMed ID: 2756462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
    Dusenbery KE; Bellairs EE; Potish RA; Twiggs LB; Boente MP
    Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy of ovarian cancer with cisplatinum, aclarubicin and tegafur].
    Wada Y; Suzuki M; Shinagawa S; Saito Y; Nishiya I; Maki M; Yajima A; Hiroi M; Sato A
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2589-94. PubMed ID: 2505683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival in ovarian cancer treated in a gynecological department of a central hospital].
    Dragsted NO; Nørgaard M; Bøsling KB
    Ugeskr Laeger; 1997 May; 159(20):3003-9. PubMed ID: 9190729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
    Del Campo JM; Felip E; Rubio D; Vidal R; Bermejo B; Colomer R; Zanon V
    Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytoreductive surgery plus combined chemotherapy for the treatment of advanced ovarian cancer].
    Li M; Huang X
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):621-3. PubMed ID: 9275460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ovarian cancers--a solution within reach?].
    Haller U; Lütolf UM; Jungi WF
    Schweiz Med Wochenschr; 1983 Sep; 113(36):1300-5. PubMed ID: 6635629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melphalan with and without doxorubicin in advanced ovarian cancer.
    Tropé C
    Obstet Gynecol; 1987 Oct; 70(4):582-6. PubMed ID: 3306509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial ovarian carcinoma: principles of primary surgery.
    Hoskins WJ
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S91-6. PubMed ID: 7835815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of ovarian cancer with combined operative, radiologic and cytostatic therapy].
    Ullrich D; Grimm D; Rothe K; Glaser FH; Heider KM; Woraschk A; Hänsgen G; Köhler L; Schöneich V
    Zentralbl Gynakol; 1985; 107(10):628-33. PubMed ID: 3160189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epithelial cancer of the ovary in adults: prognostic and therapeutic study of 95 cases].
    Fignon A; Chauvet B; Body G; Calais G; Fetissof F; Kone M; Le Floch O; Lansac J
    Ann Chir; 1990; 44(4):283-9. PubMed ID: 2192681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
    Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
    Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.